22 September 2025, FEops HEARTguide™ NEW Release
FEops announced its new release of FEops HEARTguide™, packed with innovative features, enhancing pre-planning for TAVI Lifetime management and LAAo interventions.
We are happy to announce a new version of FEops HEARTguide™ with workflows for LAAO and TAVI!
Following your feedback and suggestions, we made some changes and improvements to the TAVI and LAAO workflow.
FEops HEARTguide™ is available in EU, UK, Switserland, Canada, Australia and US markets. Please note that for TAVI, simulations are not yet available for clinical use in the US, pending 510(k) clearance.
Left, 3D Analysis of coronary access (red = gap < 2mm) Right, Leaflet overhang. Impact of commissural alignment
TAVI
Lifetime management
To address the increasing needs on TAVI lifetime management, the new release of FEops HEARTguide™ provides now for each simulation future redo-TAVI options with coronary access insights and a qualitative evaluation of the leaflet overhang*.
In the US, TAVI may be referred to as Transcatheter Aortic Valve Replacement (TAVR).
*For more details, please have a look at the training slide decks on the platform.
Updated TAVI simulation output
Next to lifetime management options, FEops HEARTguide™ will provide for each simulation of the index TAVI the following output:
New TAVI output
The skirt apposition will provide valuable insight in the sealing of the device to the anatomy, and the contact area indication will provide a qualitative insight on the contact of the device in the region of the conduction system. No quantitative evaluation of PVL nor contact pressure index is provided in the new release of FEops HEARTguide™*.
Aorta and mitral calcifications are now also visible in the simulation view (undeformed).
Updated devices
The new release of FEops HEARTguide™ extends the Medtronic Evolut range, with now also the Evolut™ FX+.
LAAO
Updated devices
The devices library for LAAO simulations was further expanded with the WATCHMAN FLX™ Pro size 40mm in the new release of FEops HEARTguide™.
Please note simulation of this device is currently not yet available for clinical use in US.
General Functionalities
Security
To further support your organization’s security requirements, multi-factor authentication and enforced password changes after a predefined time interval can now be set up. Please contact support@feops.com for support in setting this up. In addition, all users will be enforced to update their passwords, to align with the minimal password requirement of 15 characters.
Furthermore, the PDF case report has been updated, and from now onwards PDF case reports will have editable fields for patient ID, sex, age, allowing you to enter patient information or to leave the fields blank depending on your needs and your organization’s policy.
Information
Email notifications on case completion will now also be sent to the user who created the case (e.g. field specialist), in addition to the case responsible.
Optionally, upon case creation, the date of image acquisition can be added
Do not hesitate to continue sharing with us your feedback, remarks and suggestions writing at support@feops.com.
Thank you for the great collaboration!
Best regards,
The FEops – Materialise team